Supreme Court Preview: Will "Skinny Labels" Get a Weight Check?
The Supreme Court will address the issue of generic drug manufacturers and potential patent infringement in the Hikma v. Amarin case.
FDA hasn't inspected nearly 2,000 drug plants since before COVID pandemic
FDA inspections of pharmaceutical firms remain significantly behind pre-pandemic levels, raising contamination risks in critical medications.
Senate Committee Advances PREVAIL Act
The PREVAIL Act is set to change PTAB procedures, impacting patent challenges and potentially affecting generic drug pricing.
New provisions aim to balance patent protection with access to affordable medications.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
Ozempic and Wegovy could soon be challenged by China's generic competitors
Intensifying competition in Chinese market for Novo Nordisk's diabetes drug Ozempic and weight loss treatment Wegovy.
Why do hospitals keep running out of generic drugs?
Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.
Supreme Court Preview: Will "Skinny Labels" Get a Weight Check?
The Supreme Court will address the issue of generic drug manufacturers and potential patent infringement in the Hikma v. Amarin case.
FDA hasn't inspected nearly 2,000 drug plants since before COVID pandemic
FDA inspections of pharmaceutical firms remain significantly behind pre-pandemic levels, raising contamination risks in critical medications.
Senate Committee Advances PREVAIL Act
The PREVAIL Act is set to change PTAB procedures, impacting patent challenges and potentially affecting generic drug pricing.
New provisions aim to balance patent protection with access to affordable medications.
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Gilead aims to broaden access to lenacapavir through generic production in low-income countries but excludes middle-income nations, highlighting healthcare disparities.
Ozempic and Wegovy could soon be challenged by China's generic competitors
Intensifying competition in Chinese market for Novo Nordisk's diabetes drug Ozempic and weight loss treatment Wegovy.
Why do hospitals keep running out of generic drugs?
Hospitals face persistent shortages of common generic drugs due to complex market issues affecting production and distribution.